The current issued share capital of the Company, including shares issued under its blocklisting facility, is 31,799,617 ordinary shares. No shares are held as treasury.
The Directors (together with their families and their family trusts and pension scheme arrangements) in aggregate hold 418,575 ordinary shares in the Company, representing 1.32% of the Company’s current issued share capital. 36.53% of the issued share capital is not in public hands.
The Company is aware of the following significant (3% or greater) shareholdings in the Company’s ordinary shares:
Number of ordinary shares % of issued share capital
Woodford Investment Management Limited 35.39%
Arthurian Life Sciences SPV GP Ltd, as GP of The Wales Life Sciences Investment Fund LP 9.48%
The above information was last updated on Friday, 10 May 2019
http://www.reneuron.com/investors/major-shareholdings/
Good luck and GOD bless,
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM